Total (n = 32) | Group H (n = 16) | Group L (n = 16) | p value (H vs L) | |
Physical findings | ||||
SBP (mmHg) | 137 ± 11 | 137 ± 12 | 136 ± 11 | 0.712 |
DBP (mmHg) | 87 ± 9 | 86 ± 10 | 87 ± 9 | 0.728 |
BMI (kg/m2) | 22.7 [20.0 - 24.7] | 24.2 ± 4.6 | 21.9 ± 3.2 | 0.110 |
Laboratory data |
|
|
|
|
HbA1c (%) | 6.1 ± 1.0 | 6.2 ± 1.1 | 6.1 ± 1.0 | 0.882 |
Serum Alb (g/dL) | 4.4 ± 0.4 | 4.4 [4.1 - 4.6] | 4.4 ± 0.5 | 0.495 |
Serum Cr (mg/dL) | 1.28 [1.12 - 1.58] | 1.57 [1.41 - 1.76] | 1.09 ± 0.13 | - |
Serum uric acid (mg/dL) | 5.4 ± 1.3 | 5.7 ± 1.5 | 5.2 ± 1.0 | 0.304 |
Serum potassium (mmol/L) | 4.8 ± 0.5 | 4.8 [4.6 - 5.1] | 4.7 ± 0.5 | 0.335 |
Serum phosphorus (mg/dL) | 2.2 ± 0.5 | 2.3 ± 0.3 | 2.2 ± 0.6 | 0.377 |
Triglyceride (mg/dL) | 116 [94 - 165] | 128 [107 - 165] | 102 [82 - 169] | 0.200 |
HDL cholesterol (mg/dL) | 59 ± 12 | 58 ± 12 | 59 ± 13 | 0.758 |
LDL cholesterol (mg/dL) | 117 ± 29 | 117 ± 29 | 116 ± 31 | 0.930 |
Medication | ||||
Mycophenolatemofetil | 32 (100) | 16 (100) | 16 (100) | - |
Tacrolimus | 32 (100) | 16 (100) | 16 (100) | - |
Cyclosporine | 0 (0) | 0 (0) | 0 (0) | - |
Everolimus | 0 (0) | 0 (0) | 0 (0) | - |
Steroid | 32 (100) | 16 (100) | 16 (100) | - |
Antihypertensive agent | 17 (53) | 8 (50) | 9 (56) | 0.723 |
Diabetes agent | 11 (34) | 6 (38) | 5 (31) | 0.710 |
Dyslipidemia agent | 0 (0) | 0 (0) | 0 (0) | - |
Hyperuricemia agent | 1 (3) | 1 (6) | 0 (0) | 0.500 |